Does end stage renal disease increase severity of COVID-19?

Background: End stage renal disease (ESRD) patients are vulnerable to contract corona virus disease-19 (COVID-19), and they have higher risk of deterioration mortality rate compared general population. There studies on COVID-19 in end showing the low rates deterioration, most which did not develop into severe pneumonia. Objective: Compare clinical, laboratory, radiological findings with without ESRD identify factors those ESRD. Methods: We conducted a cross-sectional study involving 87 patients, consisted 43 44 non-ESRD. Data taken included age, gender, amount co-morbid, oxygen saturation when first arrived, COVID 19 symptoms (mild/moderate/severe-critical), data who died. Result: Severe-critical clinical manifestations were more common vs (p=0.012). However, was significantly different. Absolute neutrophil count neutrophil-lymphocyte ratio (NLR) As many as 24% died, 11% 13% Multivariate analysis showed that NLR ≥1 had 1.3 times death NLR<1. Conclusion: commonly found patients. The different between In ESRD, High is factor for